Exposure to bisphenols during pregnancy may increase asthma risk in young girls
Recent study data suggest that a mother’s exposure to bisphenols during pregnancy may increase a daughter’s risk of asthma.
By
Respiratory
Latest in
Respiratory
Lung Therapeutics concludes Phase Ia trial of IPF asset
Dose levels ranging from 2.5mg to 10mg of LTI-03 were demonstrated to be safe and well-tolerated.
Trevi ends enrolment early in Phase II IPF chronic cough trial after positive interim data
Haduvio offered a 77.3% decline in daytime cough frequency from baseline versus a 25.7% in the placebo arm, interim data…
Pipeline Moves: Pfizer’s hidradenitis suppurativa Phase II completion boosts further study chances
The Clinical Trials Arena team also reviews trial completions in pneumonia and cancer, as well as the likelihood of approval…
By
AN2 Therapeutics reports topline Phase Ib data of lung disease asset
Epetraborole is being developed for patients with rare, chronic and progressive non-tuberculous mycobacterial lung disease.
Immunology Trends: Asthma most mentioned term on Twitter Q4 2021
Clinical Trials Arena lists the top five terms tweeted on immunology in Q4 2021, based on data from GlobalData’s Pharmaceuticals…
Pipeline Moves: Roche Phase I suspension plummets further study chances in blood cancers
Celularity in glioblastoma multiforme and Sino Biopharm in gastric cancer are also reviewed by Clinical Trials Arena.
By
Moderna eyes combined Covid-19, flu booster by 2023
Moderna CEO Stéphane Bancel also said an Omicron-specific Covid-19 vaccine will enter clinical development in a matter of weeks.
By